David Revcolevschi is a partner in the Corporate practice of Paul Hastings and is based in the firm's Paris office. His practice focuses on French and international securities offerings, mergers and acquisitions, and more generally on the securities and corporate law and corporate governance issues faced by publicly listed companies.
Mr. Revcolevschi has extensive experience in equity and equity-linked securities offerings, representing issuers, underwriters, and shareholders. He has advised on more than 30 IPO projects and numerous other securities issuances with companies operating in the life science (biotechnology, medical device), technology, software, telecom, airlines, aerospace, real estate, leisure and entertainment, cosmetics, chemicals, utilities and financial sectors. Mr. Revcolevschi also represents issuers, directors, officers and employees in enforcement actions by the French securities regulator (AMF).
Mr. Revcolevschi draws on his French and international background and transaction experience to bridge differences between parties with different cultures on cross-border and international deals. He advises publicly listed and private companies on acquisitions, dispositions, mergers and joint ventures in a wide range of industries and his experience includes cross-border transactions involving companies and shareholders in France, the United States, China, Switzerland, the United Kingdom, Germany, Israel, Italy, Spain, Ireland, The Netherlands, Luxembourg, Poland, U.A.E and Morocco.
Equity Capital Markets Mr. Revcolevschi’s recent representations include advising:
In addition, Mr. Revcolevschi has advised issuers and underwriters on a large number of other securities offerings including:
Mergers and acquisitions Mr. Revcolevschi has notably advised:
“a consistently high performer, notably active in IPOs and privatizations” (Chambers Global) and “a cerebral practitioner who has a strong understanding of the market’s nuances” (Chambers Europe)
Aerkomm Lists on Euronext Paris
July 25, 2019
Fosun Tourism Group Completes US$428 Million Hong Kong IPO
December 14, 2018
Share Capital Increase for Wallix Group
May 24, 2018
First Swiss Company IPO on Euronext
April 18, 2016
Paul Hastings advises on IPO of Mainstay Medical International, First Irish Company to list on Euronext Paris and the Irish Stock Exchange
May 07, 2014
Paul Hastings Advises Qualcomm on its Strategic Alliance with Alcatel-Lucent
November 12, 2013
Paul Hastings European Corporate Practice Builds on Recent Additions with M&A and Capital Markets Partner in Paris
January 28, 2013
IPOs in the JOBS Act Era 2014
October 17, 2014